SEMI Issues Statement on U.S. H1-B Visa Policy Announcement
MILPITAS, Calif., Sept. 22, 2025 /PRNewswire/ -- SEMI, the industry association serving…
Bullish secures New York BitLicense from the NYDFS, paving way for U.S. launch
NEW YORK, Sept. 17, 2025 /PRNewswire/ -- Bullish (NYSE: BLSH), an institutionally…
Glac Biotech Secures U.S. Food and Drug Administration GRAS Approval for Probiotic Strain CP-9
TAIPEI, Sept. 15, 2025 /PRNewswire/ -- Glac Biotech, a Taiwan-based developer of…
HR Path Continues to Expand its Presence in the U.S. Market with the Acquisition of Next Generation Inc. (NGI)
PARIS, Sept. 10, 2025 /PRNewswire/ -- HR Path, a global leader in…
TARIFF FEARS DRIVE U.S. STOCKPILING IN AUGUST, WHILE MANUFACTURING WEAKENS IN EUROPE AND ASIA: GEP SUPPLY CHAIN VOLATILITY INDEX
North America's supply chains get busier, with sharp stockpiling of components to…
TopDawg Recognized as Most Trusted U.S. Dropshipping Supplier
FORT LAUDERDALE, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- TopDawg, the largest…
COTTONWOOD GROUP RECEIVES $1.0 BILLION IN COMMITMENTS FOR U.S. REAL ESTATE SPECIAL SITUATIONS INVESTMENT STRATEGY
The strategy targets credit and event-driven opportunities in commercial real estate located…
NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness
TORONTO and HAIFA, Israel, Sept. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic…
Novacore Innovations and GPU.ai Announce Partnership to Expand Blackwell-Powered GPU Cloud Access Across U.S. and India
MUMBAI, India, Sept. 3, 2025 /PRNewswire/ -- Mumbai's Novacore Innovations and New…
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI IQLIK(lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease Under Fast Track Status
LEQEMBI IQLIK, if approved for initiation dosing, would be the first and…
